|
1711
|
|
|
Cytochrome b561 family member A3 |
CYBASC3, LCYTB |
|
|
1712
|
|
|
Cytochrome b561 family member D1 |
- |
|
|
1713
|
|
|
Cytochrome b561 family member D2 |
101F6, TSCytb, TSP10, XXcos-LUCA11.4 |
|
|
1714
|
|
|
Cytochrome b5 type A |
CYB5, MCB5, METAG |
|
|
1715
|
|
|
Cytochrome b5 type B |
CYB5-M, CYPB5M, OMB5 |
Cardiovascular disease, Cataract, Cholecystolithiasis, Coronary artery disease, Diabetes mellitus, Gallstones, Gout, Heart failure, Metabolic syndrome, Osteoarthritis, Peripheral arterial disease, Peripheral vascular disease, Diabetes mellitus, type 2, Vascular disease |
|
1716
|
|
|
Cytochrome b5 domain containing 2 |
- |
|
|
1717
|
|
|
Cytochrome b5 reductase 1 |
B5R.1, B5R1, B5R2, NQO3A2, humb5R2 |
|
|
1718
|
|
|
Cytochrome b5 reductase 2 |
B5R.2 |
|
|
1719
|
|
|
Cytochrome b5 reductase 3 |
B5R, DIA1 |
Congenital myopathy, Congenital methemoglobinemia, Cyanosis, Cytochrome-b5 reductase deficiency, Dihydrolipoamide dehydrogenase deficiency, Intellectual developmental disorder, Methemoglobinemia, Osteoarthritis, Scoliosis, Diabetes mellitus, type 2, Venous thromboembolism |
|
1720
|
|
|
Cytochrome b5 reductase 4 |
NCB5OR, cb5/cb5R, dJ676J13.1 |
|